Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May-Jun;20(3):225-31.
doi: 10.1097/PPO.0000000000000050.

Gut microbiome and colorectal adenomas

Affiliations
Review

Gut microbiome and colorectal adenomas

Santosh Dulal et al. Cancer J. 2014 May-Jun.

Abstract

The trillions of bacteria that naturally reside in the human gut collectively constitute the complex system known the gut microbiome, a vital player for the host's homeostasis and health. However, there is mounting evidence that dysbiosis, a state of pathological imbalance in the gut microbiome is present in many disease states. In this review, we present recent insights concerning the gut microbiome's contribution to the development of colorectal adenomas and the subsequent progression to colorectal cancer (CRC). In the United States alone, CRC is the second leading cause of cancer deaths. As a result, there is a high interest in identifying risk factors for adenomas, which are intermediate precursors to CRC. Recent research on CRC and the microbiome suggest that modulation of the gut bacterial composition and structure may be useful in preventing adenomas and CRC. We highlight the known risk factors for colorectal adenomas and the potential mechanisms by which microbial dysbiosis may contribute to the etiology of CRC. We also underscore novel findings from recent studies on the gut microbiota and colorectal adenomas along with current knowledge gaps. Understanding the microbiome may provide promising new directions towards novel diagnostic tools, biomarkers, and therapeutic interventions for CRC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A. Schematic diagram of colonic microbiota and adenomas progression to CRC. Shifts in the balance of host-microbial symbiotic relationships derail the state of homeostasis (normal physiology) in the human gut. Dysbiosis, an imbalance of microbial population dynamics, is characterized by decreased beneficial commensals/symbionts, overexpression of pathogenic microbiota such as genotoxic bacteria, invasive and inflammation triggering microbiota, procarcinogenic bacteria and cancer enhancing bacterial antigens and metabolites. Consequences of the microbial dysbiosis lead to the chronic inflammation after damaging the host defenses (natural barrier) can further drive to the enhancement of small adenomas to adenocarcinoma by multistep processes. B. Proposed mechanisms of specific bacteria and CRC. The human gut microbiome drives CRC via several mechanisms. Some of the reported mechanisms of specific bacteria for the development of CRC are highlighted here.
  1. E. coli, Gram-negative facultative anaerobic bacterium, considered as one of the potential etiological agents of CRC due to its genotoxins such as Colibactin, and cytolethal distending toxin (CDT). These products could induce DNA damage and influence the progression of CRC due to genomic instability from MSI, MMR, and mutations.

  2. F. nucleatum, Gram-negative anaerobic bacterium, has been linked to CRC progression but the exact underlying mechanisms are still unknown. A potential F. nucleatum-driven CRC mechanism is its invasion into epithelial cells and activation of oncogenic and inflammatory responses through its unique FadA adhesin. Active FadA binds to E-cadherin, mediating Fusobacterium attachment and invasion into the epithelial cells. This activates β-catenin signaling, leading to increased activation of inflammatory genes (NF-κB) and secretion of cytokines interleukin-6 (IL-6), IL-8, and IL-18, and oncogenes and drives to adenoma to adenocarcinoma.

  3. E. faecalis, has been shown to produce extracellular superoxide and hydrogen peroxide, which damage DNA and also further enhances chromosomal instability in colonic epithelial cells. Chromosomal instability, a common cause of genomic instability in tumors, is characterized by nucleotide additions or deletions, inversions, translocations, and complex rearrangements, and ultimately contributes to the dramatic and unstable alteration in genomic state critical for tumor initiation in the colorectum.

  4. Gram-positive, spore forming bacteria in cluster IX of the genus Clostridium spp. convert primary bile acids into a secondary bile acid such as deoxycholic acid (DCA). DCA is widely considered as a carcinogen that is associated with DNA damage via the production of free radicals or reactive oxygen species (ROS) and implicated to adenoma-inflammation-CRC through enhancing genomic instability and inflammation.

Figure 1
Figure 1
A. Schematic diagram of colonic microbiota and adenomas progression to CRC. Shifts in the balance of host-microbial symbiotic relationships derail the state of homeostasis (normal physiology) in the human gut. Dysbiosis, an imbalance of microbial population dynamics, is characterized by decreased beneficial commensals/symbionts, overexpression of pathogenic microbiota such as genotoxic bacteria, invasive and inflammation triggering microbiota, procarcinogenic bacteria and cancer enhancing bacterial antigens and metabolites. Consequences of the microbial dysbiosis lead to the chronic inflammation after damaging the host defenses (natural barrier) can further drive to the enhancement of small adenomas to adenocarcinoma by multistep processes. B. Proposed mechanisms of specific bacteria and CRC. The human gut microbiome drives CRC via several mechanisms. Some of the reported mechanisms of specific bacteria for the development of CRC are highlighted here.
  1. E. coli, Gram-negative facultative anaerobic bacterium, considered as one of the potential etiological agents of CRC due to its genotoxins such as Colibactin, and cytolethal distending toxin (CDT). These products could induce DNA damage and influence the progression of CRC due to genomic instability from MSI, MMR, and mutations.

  2. F. nucleatum, Gram-negative anaerobic bacterium, has been linked to CRC progression but the exact underlying mechanisms are still unknown. A potential F. nucleatum-driven CRC mechanism is its invasion into epithelial cells and activation of oncogenic and inflammatory responses through its unique FadA adhesin. Active FadA binds to E-cadherin, mediating Fusobacterium attachment and invasion into the epithelial cells. This activates β-catenin signaling, leading to increased activation of inflammatory genes (NF-κB) and secretion of cytokines interleukin-6 (IL-6), IL-8, and IL-18, and oncogenes and drives to adenoma to adenocarcinoma.

  3. E. faecalis, has been shown to produce extracellular superoxide and hydrogen peroxide, which damage DNA and also further enhances chromosomal instability in colonic epithelial cells. Chromosomal instability, a common cause of genomic instability in tumors, is characterized by nucleotide additions or deletions, inversions, translocations, and complex rearrangements, and ultimately contributes to the dramatic and unstable alteration in genomic state critical for tumor initiation in the colorectum.

  4. Gram-positive, spore forming bacteria in cluster IX of the genus Clostridium spp. convert primary bile acids into a secondary bile acid such as deoxycholic acid (DCA). DCA is widely considered as a carcinogen that is associated with DNA damage via the production of free radicals or reactive oxygen species (ROS) and implicated to adenoma-inflammation-CRC through enhancing genomic instability and inflammation.

References

    1. GLOBOCON. IARC, WHO; 2012. Estimated cancer incidence, mortality and prevalence in 2012.
    1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64:9–29. - PubMed
    1. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–128. - PMC - PubMed
    1. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36:2251–2270. - PubMed
    1. Parente F, Bargiggia S, Boemo C, et al. Anatomic distribution of cancers and colorectal adenomas according to age and sex and relationship between proximal and distal neoplasms in an i-FOBT-positive average-risk Italian screening cohort. International journal of colorectal disease. 2014;29:57–64. - PubMed

Publication types